Bernard Lethé

7.8k citations

39 papers · 6.0k indexed · 4 hit papers · h-index 28

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 36
- Immunotherapy and Immune Responses 36
- T-cell and B-cell Immunology 19
- Immune Cell Function and Interaction 9
Molecular Biology 24
- vaccines and immunoinformatics approaches 17
- RNA Interference and Gene Delivery 6
- Glycosylation and Glycoproteins Research 5

Co-authors: Thierry Boon Pierre G. Coulie Christophe Lurquin Etienne De Plaen Charles De Smet Aline Van Pel Pierre van der Bruggen Vincent Brichard
Journals: The Journal of Experimental Medicine (6 papers)International Journal of Cancer (5 papers)European Journal of Immunology (4 papers)The Journal of Immunology (3 papers)Cancer Immunology Immunotherapy (2 papers)
Partner nations: Belgium France Switzerland

In The Last Decade

Bernard Lethé

39 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor 1997 · 639 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1997 Immunity
1994 Immunogenetics
1994 The Journal of Experimental Medicine
1993 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Bernard Lethé

Since Specialization

Citations

This map shows the geographic impact of Bernard Lethé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Lethé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Lethé more than expected).

Fields of papers citing papers by Bernard Lethé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Lethé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Lethé. The network helps show where Bernard Lethé may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bernard Lethé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Lethé Line = papers co-authored together Bernard Lethé links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GARP Is Regulated by miRNAs and Controls Latent TGF-β1 Production by Human Regulatory T Cells PLoS ONE ·Joanna Celińska, Ryuichi Toda, Julie Stockis, 賢二石沢, Bernard Lethé, Jean‐François Collet, Guido T. Bommer, Pierre G. Coulie, Sophie Lucas	2013	36
2	Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases Cancer Research ·Véronique Corbière, Jacques Chapiro, Vincent Stroobant, Wenbin Ma, Christophe Lurquin, Bernard Lethé, Nicolas van Baren, Benoı̂t J. Van den Eynde, Thierry Boon, Pierre G. Coulie	2011	142
3	Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family Cancer Immunology Immunotherapy ·Xiaofei Wang, Dong-Ha 김동하Kim, Florence Castelli, Christine Almunia, Bernard Lethé, Sandra Pouvelle‐Moratille, О. Т. Іванишин, Dominique Charron, Andre Ménèz, W Pflüger, Pierre van der Bruggen, Marc Busson, Bernard Maillère	2006	18
4	Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen The Journal of Experimental Medicine ·Christophe Lurquin, Bernard Lethé, Etienne De Plaen, Véronique Corbière, Ivan Théate, Nicolas van Baren, Pierre G. Coulie, Thierry Boon	2005	191
5	A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors Cancer Immunology Immunotherapy ·Zhaojun Sun, Bernard Lethé, Yi Zhang, Vincenzo Russo, Didier Colau, Vincent Stroobant, Thierry Boon, Pierre van der Bruggen	2005	10
6	Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus The Journal of Immunology ·Vaios Karanikas, Christophe Lurquin, Didier Colau, Nicolas van Baren, Charles De Smet, Bernard Lethé, Thierry Connerotte, Véronique Corbière, Marie‐Ange Demoitié, Danielle Líénard, Brigitte Dréno, Thierry Velu, Thierry Boon, Pierre G. Coulie	2003	88
7	DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter Molecular and Cellular Biology ·Charles De Smet, Christophe Lurquin, Bernard Lethé, Trung Chi Ngo, Thierry Boon	1999	499
8	Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group European Journal of Cancer ·Ulrich Keilholz, Martina Willhauck, Donata Rimoldi, F. Brasseur, Wolfgang Dummer, Knuth Rass, Taco J. De Vries, T McGuckin, Christiane Voit, Bernard Lethé, Susan A. Burchill	1998	101
9	Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor Immunity ·Hideyuki Ikeda, Bernard Lethé, Frédéric Lehmann, Nicolas van Baren, Jean‐François Baurain, Charles De Smet, Hérvè Chambost, Massimo Vitale, Alessandro Moretta, Thierry Boon, Pierre G. Coulie Hit paper breakdown →	1997	639
10	Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes Methods ·Etienne De Plaen, Christophe Lurquin, Bernard Lethé, Pierre van der Bruggen, Vincent Brichard, Jean‐Christophe Renauld, Pierre G. Coulie, Aline Van Pel, Thierry Boon	1997	51
11	The expression of mouse geneP1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen International Journal of Cancer ·Catherine Uyttenhove, Catherine Godfraind, Bernard Lethé, A Amar-Costesec, Jean‐Christophe Renauld, Thomas F. Gajewski, T. Hohn, Guy Warnier, Thierry Boon, Benoı̂t J. Van den Eynde	1997	59
12	The Majority of Autologous Cytolytic T-Lymphocyte Clones Derived from Peripheral Blood Lymphocytes of a Melanoma Patient Recognize an Antigenic Peptide Derived from Gene Pmel17/gp100 Journal of Investigative Dermatology ·Hassane M. Zarour, Charles De Smet, Frédéric Lehmann, Marie Marchand, Bernard Lethé, Pedro Romero, Thierry Boon, Jean‐Christophe Renauld	1996	47
13	A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. The Journal of Experimental Medicine ·Yannick Guilloux, Sophie Lucas, Vincent Brichard, Aline Van Pel, Christophe Viret, Etienne De Plaen, F Brasseur, Bernard Lethé, Francine Jotereau, Thierry Boon	1996	179
14	A tyrosinase nonapeptide presented by HLA‐B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes European Journal of Immunology ·Vincent Brichard, Jean Herman, Aline Van Pel, Claude Wildmann, Béatrice Gaugler, Thomas Wölfel, Thierry Boon, Bernard Lethé	1996	108
15	Structure, chromosomal localization, and expression of 12 genes of the MAGE family Immunogenetics ·Etienne De Plaen, Catia Traversari, José J. Gaforio, Jean‐Pierre Szikora, Charles De Smet, Francis Brasseur, Pierre van der Bruggen, Bernard Lethé, Christophe Lurquin, Patrick Chomez, Olivier De Backer, Thierry Boon, Karen C. Arden, Webster K. Cavenee, Robert Brasseur Hit paper breakdown →	1994	513
16	Expression of mage genes by non‐small‐cell lung carcinomas International Journal of Cancer ·P. Weynants, Bernard Lethé, F. Brasseur, M. Marchand, Thierry Boon	1994	198
17	Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. The Journal of Experimental Medicine ·Béatrice Gaugler, Benoı̂t Van den Eynde, Pierre van der Bruggen, Pedro Romero, José J. Gaforio, Florian Ainhirn, Bernard Lethé, F. Brasseur, Thierry Boon Hit paper breakdown →	1994	645
18	Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H‐2L^d and is recognized by cytotoxic T lymphocytes against mouse tumor P815 European Journal of Immunology ·Benoı̂t Van den Eynde, Honoré Mazarguil, Bernard Lethé, Françoise Laval, Jean Edouard Gairin	1994	24
19	Human T cell lines and clones respond to IL-9 The Journal of Immunology ·Frédéric Houssiau, Jean‐Christophe Renauld, Michael J. Stevens, Frédéric Lehmann, Bernard Lethé, Pierre G. Coulie, J Van Snick	1993	42
20	The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. The Journal of Experimental Medicine ·B. Van den Eynde, Bernard Lethé, Aline Van Pel, Etienne De Plaen, Thierry Boon	1991	250

About Bernard Lethé

Bernard Lethé is a scholar working on Immunology, Molecular Biology, Microbiology, Biotechnology and Oncology, having authored 39 papers that have together received 6.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (36 papers), T-cell and B-cell Immunology (19 papers), vaccines and immunoinformatics approaches (17 papers), Immune Cell Function and Interaction (9 papers), RNA Interference and Gene Delivery (6 papers), Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Immunology (5.0k citations), Oncology (2.1k citations), Molecular Biology (3.1k citations), Radiology, Nuclear Medicine and Imaging (465 citations) and Biotechnology (160 citations). Bernard Lethé has collaborated with scholars based in Belgium, France and Switzerland. Frequent co-authors include Thierry Boon, Pierre G. Coulie, Christophe Lurquin, Etienne De Plaen, Charles De Smet, Aline Van Pel, Pierre van der Bruggen, Vincent Brichard, F. Brasseur and Frédéric Lehmann. Their work appears in journals such as The Journal of Experimental Medicine, International Journal of Cancer, European Journal of Immunology, The Journal of Immunology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact